Muthoot Microfin Fund Raise of ₹3,100 Cr

Muthoot Microfin Other Announcement

Muthoot Microfin filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter and promoter group hold about 55.47%, with no transaction reported.

Muthoot Microfin Credit Rating

CareEdge reaffirmed Muthoot Microfin's long-term foreign currency rating at BB- and revised the outlook to Positive from Stable. The move reflects improving asset quality and profitability.

Muthoot Microfin Board Meeting Date

Muthoot Microfin will hold a board meeting on 5 Nov 2026 to consider Q1 FY27 unaudited standalone financial results and other business. The trading window remains closed until 7 Nov 2026.

Muthoot Microfin Other Announcement

Muthoot Microfin filed its provisional ALM statement for September 2026 as mandated by SEBI. The filing reports asset-liability mismatch and interest-rate sensitivity positions.

Muthoot Microfin Business Update

Muthoot Microfin reported its Q2 FY27 key business update, highlighting an AUM of Rs. 15,323 Crore and disbursements of Rs. 2,900 Crore.

Muthoot Microfin Debt & Borrowing

Muthoot Microfin Limited submitted its half-yearly statement of outstanding debt securities and commercial papers for the period ended September 30, 2026. The report lists active ISINs.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.